The US Food and Drug Administration (FDA) has approved a chimeric antigen receptor (CAR)-T cell immunotherapy for the treatment of multiple myeloma. The first-in-class BCMA-directed CAR-T therapy received the agency’s go-ahead on 26 March.
In a historic move, the US government has announced that it supports waiving patent protections for COVID-19 vaccines, a measure aimed at boosting supplies so that people around the world can get the shots.
Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines.
The WHO has approved one of China’s COVID-19 vaccines for use worldwide and another is under review. But published trial data remain scarce.
Seasoned science entrepreneurs tell Adam Levy how to take the daunting first steps to commercializing your research.
Scientist-turned-lawyer Tamsen Valoir outlines a key step on the road to commercializing your research.